Source: Nasdaq

Quest Diagnostics: Is Quest Diagnostics Stock Outperforming the S&P 500?

Although Quest Diagnostics has outperformed the S&P 500 Index over the past year, analysts are cautiously optimistic about the stock's prospects.

Read full article »
Annual Revenue
$5.0-10B
Employees
50-100K
James Davis's photo - President & CEO of Quest Diagnostics

President & CEO

James Davis

CEO Approval Rating

63/100

Read more